Somatic mutations in IFN-γ-Signal molecules in human uterine leiomyosarcoma
Uterus Leiomyosarcoma (uLMS), unfortunately, is a dis-ease with a poor prognosis. In the report of the Ministry of Health, Labor and Welfare, the 50% survival time (mOS) summarized from Stage I to Stage IV was 31months. Pre-operative diagnosis of uLMS is very difficult. Although it is diagnosed as “...
Main Author: | Tonegawa, Susumu |
---|---|
Other Authors: | Picower Institute for Learning and Memory |
Format: | Article |
Language: | English |
Published: |
MedDocs Publishers LLC
2020
|
Online Access: | https://hdl.handle.net/1721.1/124936 |
Similar Items
-
The somatic mutations in Interferon-γ signal molecules in human uterine leiomyosarcoma
by: Hayashi, Takuma, et al.
Published: (2018) -
Identification Of Novel Biomarker For Human Uterine Leiomyosarcoma
by: Hayashi, Takuma, et al.
Published: (2018) -
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
by: Hayashi, Takuma, et al.
Published: (2011) -
Pathobiology of Human Uterine Leiomyosarcoma for Development of Novel Diagnosis and Clinical Therapy
by: Hayashi, Takuma, et al.
Published: (2018) -
Tumor Immunoediting, from T Cell-Mediated Immune Surveillance to Tumor-Escape of Uterine Leiomyosarcoma
by: Hayashi, Takuma, et al.
Published: (2018)